Login

Company Executives

$ Management Team

Dr. David Parkinson

President

Chief Executive Officer

Director

Age 74
Compensation $4.057M USD
Sex Male

Mr. David Wood

Chief Financial Officer

Age 63
Compensation $1.656M USD
Sex Male

Mr. Peter Virsik

Chief Operating Officer

Executive Vice President

Age -
Compensation $1.690M USD
Sex Male

Dr. Alessandra Cesano

Executive Vice President

Chief Medical Officer

Age 64
Compensation $2.486M USD
Sex Female

Dr. Richard Glickman

Non-Executive Independent Chairman of the Board

Age 67
Compensation $707.6K USD
Sex Male
Directors
10
serving now
Independent
9 of 10
stated in the proxy
Average tenure
Not stated
from year joined
CEO also chairs the board
No
Richard Glickman
Director Age On board Independent Committees Other public boards 2024 pay Source
Richard Glickman
Not stated Not stated Independent
Compensation Committee
Eupraxia Pharmaceuticals Inc., enGene Holdings Inc. $707,644
Gary Sollis
Not stated Not stated Independent
Audit Committee
None stated $504,388
Franklin M. Berger
Not stated Not stated Independent None stated Atea Pharmaceuticals Inc., Kezar Life Sciences Inc., Satellos Bioscience Inc. $504,388
Scott Requadt
Not stated Not stated Independent
Compensation Committee · Chair
None stated $501,388
Sanford Zweifach
Not stated Not stated Independent None stated Compugen Ltd., Carisma Therapeutics Inc. $502,388
Alex Martin
Not stated Not stated Independent
Compensation Committee
None stated $492,388
Marella Thorell
Not stated Not stated Independent
Audit Committee · Chair
Carisma Therapeutics Inc. $502,138
Philip Kantoff
Not stated Not stated Independent None stated Context Therapeutics Inc. $489,388
Lauren Merendino
Not stated Not stated Independent None stated None stated $265,444
David R. Parkinson
Not stated Not stated Not independent None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jan 22, 2025 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support